Annual Short Term Debt
$155.10 K
+$8000.00+5.44%
June 1, 2024
Summary
- As of February 26, 2025, NEUP annual short term debt is $155.10 thousand, with the most recent change of +$8000.00 (+5.44%) on June 1, 2024.
- During the last 3 years, NEUP annual short term debt has risen by +$24.20 thousand (+18.49%).
Performance
NEUP Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
$149.60 K
-$14.90 K-9.06%
December 1, 2024
Summary
- As of February 26, 2025, NEUP quarterly short term debt is $149.60 thousand, with the most recent change of -$14.90 thousand (-9.06%) on December 1, 2024.
- Over the past year, NEUP quarterly short term debt has stayed the same.
Performance
NEUP Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
NEUP Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.4% | 0.0% |
| 3 y3 years | +18.5% | - |
| 5 y5 years | -97.4% | -97.5% |
NEUP Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -29.0% | -83.1% | -26.4% |
| 5 y | 5-year | -97.4% | -29.0% | -97.5% | -26.4% |
| alltime | all time | -97.6% | -53.8% | -97.7% | -52.1% |
Neuphoria Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $149.60 K(-9.1%) |
| Sep 2024 | - | $164.50 K(-81.4%) |
| Jun 2024 | $155.10 K(+5.4%) | - |
| Dec 2023 | - | $885.30 K(+501.8%) |
| Jun 2023 | $147.10 K(+33.6%) | $147.10 K(+30.4%) |
| Dec 2022 | - | $112.80 K(+2.5%) |
| Jun 2022 | $110.10 K(-15.9%) | $110.10 K(-1.6%) |
| Dec 2021 | - | $111.90 K(-14.5%) |
| Jun 2021 | $130.90 K(-96.8%) | $130.90 K(-97.7%) |
| Dec 2020 | - | $5.71 M(+39.7%) |
| Jun 2020 | $4.09 M(-30.9%) | $4.09 M(-32.3%) |
| Dec 2019 | - | $6.05 M(+2.1%) |
| Jun 2019 | $5.92 M(+38.1%) | $5.92 M(-1.5%) |
| Dec 2018 | - | $6.01 M(+40.2%) |
| Jun 2018 | $4.29 M(-34.4%) | $4.29 M(+191.0%) |
| Dec 2017 | - | $1.47 M(-77.4%) |
| Jun 2017 | $6.53 M(+125.7%) | $6.53 M(+31.5%) |
| Dec 2016 | - | $4.97 M(+71.6%) |
| Jun 2016 | $2.89 M(-30.9%) | $2.89 M(-24.0%) |
| Dec 2015 | - | $3.81 M(-9.0%) |
| Jun 2015 | $4.19 M(+464.0%) | $4.19 M(+117.9%) |
| Dec 2014 | - | $1.92 M(+158.8%) |
| Jun 2014 | $742.50 K(+19.6%) | $742.50 K(+21.5%) |
| Dec 2013 | - | $611.00 K(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | $620.90 K(-17.2%) | $620.90 K(-15.7%) |
| Dec 2012 | - | $736.60 K(-1.8%) |
| Jun 2012 | $750.00 K(-75.2%) | $750.00 K(+6.1%) |
| Dec 2011 | - | $706.60 K(-76.6%) |
| Jun 2011 | $3.02 M(+467.2%) | $3.02 M(+444.1%) |
| Dec 2010 | - | $555.40 K(+4.2%) |
| Jun 2010 | $532.80 K(+24.8%) | $532.80 K(+10.8%) |
| Dec 2009 | - | $481.00 K(+12.7%) |
| Jun 2009 | $426.90 K(-22.0%) | $426.90 K(-0.6%) |
| Dec 2008 | - | $429.40 K(-21.6%) |
| Jun 2008 | $547.40 K(+19.2%) | $547.40 K(+11.8%) |
| Dec 2007 | - | $489.70 K(+6.6%) |
| Jun 2007 | $459.40 K(+49.6%) | $459.40 K(+35.9%) |
| Dec 2006 | - | $338.00 K(+10.1%) |
| Jun 2006 | $307.10 K(+12.4%) | $307.10 K(+13.1%) |
| Dec 2005 | - | $271.50 K(-0.6%) |
| Jun 2005 | $273.10 K(-23.2%) | $273.10 K(-31.2%) |
| Dec 2004 | - | $396.70 K(+11.6%) |
| Jun 2004 | $355.40 K(+3.7%) | $355.40 K(-7.1%) |
| Dec 2003 | - | $382.60 K(+11.7%) |
| Jun 2003 | $342.60 K(+378.5%) | $342.60 K(+60.3%) |
| Dec 2002 | - | $213.70 K(+198.5%) |
| Jun 2002 | $71.60 K(-46.4%) | $71.60 K |
| Jun 1999 | $133.50 K | - |
FAQ
- What is Neuphoria Therapeutics annual short term debt?
- What is the all time high annual short term debt for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual short term debt year-on-year change?
- What is Neuphoria Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly short term debt year-on-year change?
What is Neuphoria Therapeutics annual short term debt?
The current annual short term debt of NEUP is $155.10 K
What is the all time high annual short term debt for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual short term debt is $6.53 M
What is Neuphoria Therapeutics annual short term debt year-on-year change?
Over the past year, NEUP annual short term debt has changed by +$8000.00 (+5.44%)
What is Neuphoria Therapeutics quarterly short term debt?
The current quarterly short term debt of NEUP is $149.60 K
What is the all time high quarterly short term debt for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly short term debt is $6.53 M
What is Neuphoria Therapeutics quarterly short term debt year-on-year change?
Over the past year, NEUP quarterly short term debt has changed by $0.00 (0.00%)